Experimental considerations for cell secretome-based metabolomics investigationsExperimental considerations for cell secretome-based metabolomics investigations

Autor: Daskalakis, Evangelia, Pillon, Nicolas J, Krook, Anna, Checa, Antonio, Wheelock, Craig E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c60454a8a47106e12153364af01cebe

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.

Autor: Tribble JR; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden., Jöe M; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden., Varricchio C; School of Pharmacy and Pharmaceutical Sciences; Cardiff University, Cardiff, Wales, UK., Otmani A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden., Canovai A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden.; Department of Biology, University of Pisa, 56127, Pisa, Italy., Habchi B; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.; C2VN, INRAE, INSERM, Aix Marseille University, 13007, Marseille, France., Daskalakis E; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden., Chaleckis R; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.; Gunma Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan., Loreto A; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK.; School of Medical Sciences and Save Sight Institute, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Gilley J; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK., Wheelock CE; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden., Jóhannesson G; Department of Clinical Sciences, Ophthalmology, Umeå University, 901 85, Umeå, Sweden.; Wallenberg Centre of Molecular Medicine, Umeå University, 901 85, Umeå, Sweden., Wong RCB; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia., Coleman MP; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK., Brancale A; School of Pharmacy and Pharmaceutical Sciences; Cardiff University, Cardiff, Wales, UK.; Vysoká škola chemicko-technologická v Praze, Prague, Czech Republic., Williams PA; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden. pete.williams@ki.se.

Publikováno v: Nature communications [Nat Commun] 2024 Sep 17; Vol. 15 (1), pp. 8143. Date of Electronic Publication: 2024 Sep 17.